Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia

Children with immune thrombocytopenia for ≥6 months completing a romiplostim study received weekly subcutaneous romiplostim (1-10 μg/kg targeting platelet counts of 50-200×10(9)/L) in this extension to examine romiplostim’s long-term safety and efficacy. Sixty-five children received romiplostim for...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Haematologica
Hlavní autoři: Tarantino, Michael D., Bussel, James B., Blanchette, Victor S., Beam, Donald, Roy, John, Despotovic, Jenny, Raj, Ashok, Carpenter, Nancy, Mehta, Bhakti, Eisen, Melissa
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6821612/
https://ncbi.nlm.nih.gov/pubmed/30846500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.202283
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky